Nautilus Biotechnology, Inc.
NAUT
$1.00
-$0.01-1.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -56.52M | -57.09M | -59.00M | -62.81M | -65.69M |
| Total Depreciation and Amortization | 5.97M | 6.32M | 6.47M | 6.51M | 6.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.99M | 5.09M | 5.42M | 7.34M | 8.61M |
| Change in Net Operating Assets | -4.67M | -4.18M | -3.58M | -3.67M | -4.14M |
| Cash from Operations | -50.24M | -49.86M | -50.70M | -52.63M | -54.71M |
| Capital Expenditure | -1.63M | -1.57M | -1.28M | -2.05M | -2.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.12M | 31.51M | 36.50M | 73.59M | 65.93M |
| Cash from Investing | 27.49M | 29.95M | 35.22M | 71.54M | 63.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.45M | 1.30M | 214.00K | 553.00K | 693.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.45M | 1.30M | 214.00K | 553.00K | 693.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.29M | -18.61M | -15.26M | 19.47M | 9.57M |